We narrowed to 7,988 results for: 104

#76104

3rd generation lentiviral gRNA plasmid targeting human MAST3

John Doench, David Root

Doench et al Nat Biotechnol. 2016 Jan 18. doi: 10.103

July 6, 2016

Academic Institutions and Nonprofits only

#188635

ATAD2 overexpression

Lorenz Studer

Baggiolini et al Science. 2021 Sep 3;373(6559):eabc1048.

Nov. 14, 2022

Academic Institutions and Nonprofits only

#131045

Plasmid encoding Cas9-53BP1-DN1S fusion with BbsI restriction sites for insertion of guide RNA sequence.

Punam Malik

Jayavaradhan et al Nat Commun. 2019 Jun 28;10(1):2866. doi:

Oct. 1, 2019

Academic Institutions and Nonprofits only

#201104

expression of human ERBB3 receptor tyrosine kinase in mammalian cells

Pavel Krejčí

Gudernova et al Elife. 2017 Feb 15;6. pii: e21536. doi:

May 26, 2023

Academic Institutions and Nonprofits only

#179104

PASTEv1 PE2-P2A-Bxb1

Omar Abudayyeh, Jonathan Gootenberg

Yarnall et al Nat Biotechnol. 2022 Nov 24. doi: 10.103

Feb. 19, 2022

Academic Institutions and Nonprofits only

#154104

Mammalian expression plasmid for dimeric soluble ACE2 (IgG1-Fc fusion)

Erik Procko

Chan et al Science. 2020 Sep 4;369(6508):1261-1265.

June 24, 2020

Academic Institutions and Nonprofits only

#137066

E. coli expression clone (T7lac promoter) for mature HtrA (aa 28-474) from B. burgdorferi with N-terminal PelB signal peptide + His10 + mature maltose binding protein + TEV protease cleavage

Debra Hansen

Robertson et al Sci Rep. 2019 Nov 26;9(1):17606. doi: 10

April 17, 2020

Academic Institutions and Nonprofits only

#161104

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161042

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161044

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits